Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press84810.17650/1994-4098-2021-17-2-81-92GYNECOLOGY. ORIGINAL REPORTSГИНЕКОЛОГИЯ. ОРИГИНАЛЬНЫЕ СТАТЬИGlassy cell carcinoma of cervixСтекловидноклеточные карциномы шейки маткиSafronovaK. V.СафроноваК. В.
Russian Federation

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia

41 Kirochnaya St., Saint Petersburg 191015, Russia

Россия, 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

Россия, 191015 Санкт-Петербург, ул. Кирочная, 41

kristina-skalli@yandex.ruArtemievaA. S.АртемьеваА. С.
Russian Federation

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia

Россия, 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

UlrikhE. A.УльрихЕ. А.
Russian Federation

41 Kirochnaya St., Saint Petersburg 191015, Russia

2 Akkuratova St., Saint Petersburg 197341, Russia

Россия, 191015 Санкт-Петербург, ул. Кирочная, 41

Россия, 197341 Санкт-Петербург, ул. Аккуратова, 2

https://orcid.org/0000-0001-6937-2740BerlevI. V.БерлевИ. В.
Russian Federation

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia

41 Kirochnaya St., Saint Petersburg 191015, Russia

Россия, 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

Россия, 191015 Санкт-Петербург, ул. Кирочная, 41

UrmancheevaA. F.УрманчееваА. Ф.
Russian Federation

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia

41 Kirochnaya St., Saint Petersburg 191015, Russia

Россия, 197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

Россия, 191015 Санкт-Петербург, ул. Кирочная, 41

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Петрова» Минздрава РоссииI.I. Mechnikov North-Western State Medical University, Ministry of Health RussiaФГБОУ ВО «Северо-Западный государственный медицинский университет им. И. И. Мечникова» Минздрава РоссииV.A. Almasova National Medical Research Oncology Center, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России200920211721809202118092021https://ojrs.abvpress.ru/ojrs/article/view/848

Objective: to identify the features of the frequency of occurrence, clinical presentation, methods of diagnosis and treatment of vitreous cell carcinomas of the cervix.

Materials and methods. The publication highlights 4 cases of diagnosed GCC of the cervix at the N. N. Petrov National Medical Research Oncology Center for a five-year period from 2015 to 2020.

Results. The incidence of vitreous cell carcinomas of the cervix is 1.08 % of all cases of cervical cancer. The study included only patients with locally advanced forms of stage II and III diseases. All patients underwent individualized treatment. In three cases, progression of the disease was observed during treatment.

Conclusions. The main problem is the rare occurrence of vitreous cell carcinomas of the cervix. The choice of treatment tactics is decided only on a multidisciplinary basis and requires further research.

Цель исследования – выявить особенности частоты встречаемости, клинической картины, методов диагностики и лечения стекловидноклеточных карцином (glassy cell carcinoma, GCC) шейки матки.

Материалы и методы. В публикации освещены 4 случая диагностированных GCC шейки матки в ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Петрова» Минздрава России за 5‑летний период – с 2015 по 2020 г.

Результаты. Частота встречаемости GCC шейки матки составляет 1,08 % всех случаев рака шейки матки. Все пациентки в исследовании имели местно-распространенную форму заболевания II и III стадий. Всем пациенткам проводилось индивидуализированное лечение. Во всех случаях наблюдалось прогрессирование заболевания на фоне проводимого лечения.

Выводы. Основная проблема заключается в редкой встречаемости GCC шейки матки. Выбор тактики лечения решается только мультидисциплинарно и требует дальнейших исследований.

cervical cancervitreous cell carcinomaglassy cell carcinomaadenocarcinomaрак шейки маткистекловидноклеточная карциномааденокарциномаMalignant tumors in Russia in 2019 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzodova. Moscow: P.A. Herzen Moscow Oncology Research Institute – a branch of the National Medical Research Center of Radiology, Ministry of Health of Russia, 2020. 252 p. (In Russ.).Злокачественные новообразования в России в 2019 году(заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Злокачественные новообразования в России в 2019 году(заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава Рос- сии, 2020. 252 с.Guitarte C., Alagkiozidis I., Mize B. et al. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis. Gynecol Oncol 2014;133:186–91. DOI: 10.1016/j.ygyno.2014.01.048.Alfsen G.C., Thoresen S.O., Kristensen G.B. et al. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 2000;89(6):1291–9.SEER Cancer Statistics Review. Eds.: Ries L.A.G., Harkins D., Krapcho M. et al. Bethesda: National Cancer Institute, 1975–2003.Glucksmann A., Cherry C. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer 1956;9:971–9. DOI: 10.1002/1097-0142(195609/10)9:5<971::aid-cncr2820090518>3.0.co;2-t.Littman P., Clement P.B., Henriksen B. et al. Glassy cell carcinoma of the cervix. Cancer 1976;37:2238–46. DOI: 10.1002/1097-0142(197605)37:5<2238::aid-cncr2820370513>3.0.co;2-d.Kurman R.J., Carcangiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumors of Female Reproductive Organs. Lyon: International Agency for Research on Cancer, 2014.Lotocki R.J., Krepart G.V., Paraskevas M. et al. Glassy cell carcinoma of the uterine cervix: a bimodal treatment strategy. Gynecol Oncol 1992;44:254–9. DOI: 10.1016/0090-8258(92)90052-k.Kim S.K., Shim H.S., Lee K.G. et al. Glassy cell carcinoma predominantly commits to a squamous lineage and is strongly associated with high-risk type human papillomavirus infection. Int J Gynecol Pathol 2009;28:389–95. DOI: 10.1097/PGP.0b013e31819343a5.Kenny M.B., Unger E.R., Chenggis M.L., Costa MJ. In situ hybridization for human papillomavirus DNA in uterine adenosquamous carcinoma with glassy cell features (“glassy cell carcinoma”). Am J Clin Pathol 1992;98(2):180–7.Gray H.J., Garcia R., Tamimi H.K. et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 2002;85:274–7. DOI: 10.1006/gyno.2001.6523.Reis-Filho J.S., Fillus Neto J., Schonemann E. et al. Glassy cell carcinoma of the uterine cervix. Report of a case with cytohistologic and immunohistochemical study. Acta Cytol 2001;45: 407–10. DOI: 10.1159/000327639.Deshpande A., Kotwal M., Bobhate S. Glassy cell carcinoma of the uterine cervix: a rare histology. Report of three cases with a review of the literature. Indian J Cancer 2004;41:92–5.Costa M.J., Kenny M.B., Hewan-Lowe K., Judd R. Glassy cell features in adenosquamous carcinoma of the uterine cervix – histologic, ultrastructural, immunohistochemical and clinical findings. Am J Clin Pathol 1991;96:520–8.Zhu H.T., Li S.X. Glassy cell carcinoma of the cervix: a clinicopathologic analysis of 5 cases Chin. J Pathol 2011;40(8):523–7.Piura B., Rabinovich A., Meirovitz M., Yanai-Inbar I. Glassy cell carcinoma of the uterine cervix. J Surg Oncol 1999;72:206–10.Nasu K., Takai N., Narahara H. Multimodal treatment of glassy cell carcinoma of the uterine cervix. J Obstet Gynaecol Res 2009;35(3):584–7.Ferrandina G., Salutari V., Petrillo M. et al. Conservatively treated glassy cell carcinoma of the cervix. World J Surg Oncol 2008;6:92.Nahhas W.A., Abt A.B., Mortel R. Stage IB glassy cell carcinoma of the cervix with ovarian metastasis. Gynecol Oncol 1977;5:87–91.Reisinger S.A., Palazzo J.P., Talerman A. et al. Stage IB glassy cell carcinoma of the cervix diagnosed during pregnancy and recurring in transposed ovary. Gynecol Oncol 1991;42:86–90.Hirashima Y., Kobayashi H., Nishiguchi T. et al. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin. Anticancer Drugs 2001;12:627–30. DOI: 10.1097/00001813-200108000-00010.Matsuura Y., Murakami N., Nagashio E. et al. Glassy cell carcinoma of the uterine cervix: combination chemotherapy with paclitaxel and carboplatin in recurrent tumor. J Obstet Gynecol Res 2001;27:129–32.Takekuma M., Hirashima Y., Takahashi N. et al. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin. Anticancer Drugs 2006;17:715–8. DOI: 10.1097/01.cad.0000217420.14090.a9.Nagai T., Okubo T., Sakaguchi R. et al. Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. Int J Clin Oncol 2008;13:541–4.Mikami M., Ezawa S., Sakaiya N. et al. Response of glassy cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C. Lancet 2000;355:1159–60.Inoue T., Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA and IIB: a study of 628 cases treated by radical hysterectomy and lymphadenectomy with and without postoperative radiation. Cancer 1984;54:1714–9.DOI: 10.1002/1097-0142(19841015)54:8<1714::aidcncr2820540838>3.0.co;2-s.Sevin B.U., Lu Y., Bloch D. et al. Surgically defined prognostic parameters in patients with early cervical carcinoma: a multivariate survival tree analysis. Cancer 1996;78:1438–46.Zreik T.G., Chambers J.T., Chambers S.K. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstetric Gynecol 1996;87:741–6.Estape R.E., Angioli R., Madrigal M. et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol 1998;68:229–32. DOI: 10.1006/gyno.1998.4960.Peters W.A., Liu P.Y, Barrett R.J. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606–13.Koh W.J., Panwala K., Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol 2000;10:51–60.Kuroda H., Toyozumi Y., Masuda T. et al. Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and HER2/neu protein. Acta Cytol 2006;50:418–22. DOI: 10.1159/000325985.Kosinska-Kaczynska K., Mazanowska N., Bomba-Opon D. et al. Glassy cell carcinoma of the cervix – a case report with review of the literature. Ginekol Pol 2011;82:936–9.Dieterle S., Mesrogli M., Gunter H.H., Kuhnle H. Glassy cell carcinoma of the cervix. Geburtshilfe Frauenheilkd 1991;51:484–5.Corn B.W., Micaily B., Dunton C.J. et al. Concomitant irradiation and doseescalating carboplatin for locally advanced carcinoma of the uterine cervix. An updated report. Am J Clin Oncol 1998;21:31–5.Seltzer V., Sall S., Castadot M.J. et al. Glassy cell cervical carcinoma. Gynecol Oncol 1979;8:141–51.Hopkins M., Morley G. Glassy cell adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 2004;190:67–70. DOI: 10.1016/s0002-9378(03)00928-1.Tamimi H.K., Ek M., Hesla J. et al. Glassy cell carcinoma of the cervix redefined. Obstet Gynecol 1988;71:837–41.Talerman A., Alenghat E., Okagaki T. Glassy cell carcinoma of the uterine cervix. APMIS Suppl 1991;23:119–25.Yoon N., Yoon G., Park C.K., Kim H.S. Stromal p16 expression is significantly increased in malignant ovarian neoplasms. Oncotarget 2016;7(40):64665–73. DOI: 10.18632/oncotarget.11660.Safronova K.V., Artemyeva A.S., Sidoruk A.A. et al. Melanoma of the lower female genital tract (vulva, vagina, and cervix): analysis of 22 cases and literature review. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of the Female Reproductive System 2019;15(3):44–53. (In Russ.).Сафронова К.В., Артемьева А.С., Сидорук А.А. и др. Меланома нижнего женского полового тракта (вульвы, влагалища и шейки матки): обзор литературы и собственные наблюдения. Опухоли женской репродуктивной системы 2019;15(3):44–53.Safronova K.V., Artemyeva A.S., Nyuganen A.O. et al. Sarcomas of the lower female genital tract (vulva, vagina, and cervix): analysis of 42 cases and literature review. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of the Female Reproductive System 2019;15(3):54–63. (In Russ.).Сафронова К.В., Артемьева А.С., Нюганен А.О. и др. Саркомы нижнего женского полового тракта (вульвы, влагалища и шейки матки): обзор литературы и собственные наблюдения. Опухоли женской репродуктивной системы 2019;15(3):54–63.